Current Clinical Pharmacology
Title:Editorial: Are We in Need for Novel Therapeutics in Anxiety Disorders? (Thematic Issue: Non-Antidepressant Long Term Treatment of Anxiety Disorders)
Volume: 10 Issue: 2
Author(s): Rami Bou Khalil
Affiliation:
Export Options
About this article
Cite this article as:
Khalil Bou Rami, Editorial: Are We in Need for Novel Therapeutics in Anxiety Disorders? (Thematic Issue: Non-Antidepressant Long Term Treatment of Anxiety Disorders), Current Clinical Pharmacology 2015; 10 (2) . https://dx.doi.org/10.2174/157488471002150723144817
DOI https://dx.doi.org/10.2174/157488471002150723144817 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Leptinaemia and Antiendothelial Antibodies in Accelerated Atherosclerosis – Is There a Relationship?
Vascular Disease Prevention (Discontinued) Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy?
Current Pharmaceutical Design Flavonoids and Dementia: An Update
Current Medicinal Chemistry Current Developments for the Diagnosis and Treatment of Irritable Bowel Syndrome
Current Pharmaceutical Design Immunotherapy in Breast Cancer- Paving New Roads?
Current Molecular Pharmacology Multifunctional Tacrine Derivatives in Alzheimer’s Disease
Current Topics in Medicinal Chemistry Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects
Current Neuropharmacology Glycine Transporter 1 Inhibitors and Modulation of NMDA Receptor-Mediated Excitatory Neurotransmission
Current Drug Targets The Glutamatergic Hypothesis for Down Syndrome: The Potential Use of N-Methyl-D-Aspartate Receptor Antagonists to Enhance Cognition and Decelerate Neurodegeneration
CNS & Neurological Disorders - Drug Targets Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery
Current Pharmaceutical Design Editorial (Thematic Selection: Mitochondrial Dysfunction & Neurological Disorders)
Current Neuropharmacology CA125: An Increasingly Promising Biomarker of Heart Failure
Current Pharmaceutical Design Neonatal Withdrawal Reactions Following Late in Utero Exposure to Antidepressant Medications
Current Women`s Health Reviews A Membrane is Born: Origin of the Autophagosomal Compartment
Current Molecular Medicine Synopsis of Expert Opinions and Conclusions
CNS & Neurological Disorders - Drug Targets Management of Adverse Effects from Medications Used to Treat Substance Use Disorders
Current Psychopharmacology Non-IgE Mediated Food Allergy
Inflammation & Allergy - Drug Targets (Discontinued) Nicotinic Acetylcholine Receptor Agonists: A Potential New Class of Analgesics
Current Topics in Medicinal Chemistry Treatment of Refractory Autoimmune Diseases with Ablative Immunotherapy Using Monoclonal Antibodies and / or High Dose Chemotherapy with Hematopoietic Stem Cell Support
Current Pharmaceutical Design The Cannabinoids Switch of Oxidative Stress: A Double-Edged Sword
Mini-Reviews in Organic Chemistry